Obesity Discussion Forums - View Single Post - Increasing Incidence of Obesity Drives Demand in the Global CLA Markets

Obesity Discussion · 05-03-07, 07:49 PM

Increasing Incidence of Obesity Drives Demand in the Global CLA Markets

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c55851) has announced the addition of “Strategic Analysis of the Global CLA Markets” to their offering.
This Frost & Sullivan research service titled Strategic Analysis of the Global CLA Markets provides an overview of market dynamics and trends, along with a complete analysis of key application sectors. The study also includes market drivers, restraints and strategic recommendations. In this research, Frost & Sullivan's expert analysts thoroughly examine the following applications: dietary supplements, food and beverage, animal feed.
Increasing Incidence of Obesity Drives Demand in the Global CLA Markets
The incidence of obesity has gained an epidemic proportion worldwide and is one of the major health challenges in the 21st century. The WHO has reported that obesity is the vital factor behind rising health care costs at a global level. With the obesity epidemic continuing to make headlines, the weight loss ingredients market is likely to witness significant growth. However, incidences such as the ban of ephedra in 2004 have increased consumer scepticism about the credibility and use of weight loss ingredients. Currently, the weight loss ingredients market demands ingredients that are backed by clinical evidence. This need has been addressed by conjugated linoleic acid (CLA) manufacturers to a very large extent and the CLA market is characterised by a high level of research and development (R&D) activities. In the geographical context, the United States and Europe are developed markets for CLA, accounting for 85 per cent of the revenues. Meanwhile, Asia is an emerging market, with Japan being the only developed market for CLA, while other countries such as China, Thailand and Korea are potential markets.
The increasing incidence of obesity and associated healthcare expenditure have encouraged consumer interest towards weight loss supplements. "The rising incidence of obesity is the key factor driving growth in the global CLA market," notes the analyst of this research service. "In addition, burgeoning health care costs have stimulated consumer interest towards preventive medication." This has augmented the consumption of dietary supplements, which is further propelling growth in the CLA market. Apart from this, heightened media coverage on the ill-effects of obesity has increased consumer awareness and created interest in weight management. Increasing scientific evidence on the efficiency of CLA in weight management and growing demand for fortified foods have encouraged food and beverage manufacturers to incorporate CLA in their products. Moreover, rising scientific evidence of the ability of CLA to alleviate conditions such as diabetes and cardiovascular diseases is likely to open up viable business opportunities for CLA.
Resolving Legislative Issues Crucial for Market Growth
The uncertain regulatory scenario is a vital factor restricting the use of CLA in a number of applications such as food and beverage, as well as animal feed. In Europe, the regulatory status of CLA is in a grey area as it was introduced prior to the EU's Novel Foods Regulation in 1997. Food ingredients introduced prior to this regulation do not require safety approval by the EC. In addition, according to the French Food Authority, Agence Française de Sécurité Sanitaire des Aliments (AFSSA), the use of CLA in foods and supplements is not justified. "In the United States, CLA holds a self-affirmed GRAS status," remarks the analyst. "While this status of CLA has supported its use in the dietary supplements industry, there are still uncertainties associated with the use of CLA, which have created ambiguity among food and beverage manufacturers regarding the use of this ingredient." Consequently, potential volumes in the food and beverage and animal feed sectors have been restricted. Thus, CLA is largely used as a dietary supplement and its use in the food and beverage, as well as the animal feed industries is significantly hindered by regulatory issues. Nevertheless, these industries are potential application areas, which are likely to witness strong growth rates once legislative issues are resolved.
It has been observed that manufacturers are currently focusing on resolving the legislative issues associated with CLA. By working in close coordination with legislative organisations and providing a balanced view on the use of CLA in foods, manufacturers can enhance credibility and encourage its use by food manufacturers. Manufacturers are also likely to benefit from marketing and advertising campaigns aimed at increasing consumer awareness of CLA.

Obesity

05-03-07, 07:49 PM	#1 (permalink)
Obesity Discussion Administrator Join Date: Jan 2005 Location: Phoenix, AZ Posts: 7,874 Weight Statistics 8/1/2006 Start Date: 185 lb Start Weight: 152 lb Current Weight: 155 lb Goal Weight: -33 lb Weight Loss: 5/1/2007 Goal Date:	Increasing Incidence of Obesity Drives Demand in the Global CLA Markets Increasing Incidence of Obesity Drives Demand in the Global CLA Markets DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c55851) has announced the addition of “Strategic Analysis of the Global CLA Markets” to their offering. This Frost & Sullivan research service titled Strategic Analysis of the Global CLA Markets provides an overview of market dynamics and trends, along with a complete analysis of key application sectors. The study also includes market drivers, restraints and strategic recommendations. In this research, Frost & Sullivan's expert analysts thoroughly examine the following applications: dietary supplements, food and beverage, animal feed. Increasing Incidence of Obesity Drives Demand in the Global CLA Markets The incidence of obesity has gained an epidemic proportion worldwide and is one of the major health challenges in the 21st century. The WHO has reported that obesity is the vital factor behind rising health care costs at a global level. With the obesity epidemic continuing to make headlines, the weight loss ingredients market is likely to witness significant growth. However, incidences such as the ban of ephedra in 2004 have increased consumer scepticism about the credibility and use of weight loss ingredients. Currently, the weight loss ingredients market demands ingredients that are backed by clinical evidence. This need has been addressed by conjugated linoleic acid (CLA) manufacturers to a very large extent and the CLA market is characterised by a high level of research and development (R&D) activities. In the geographical context, the United States and Europe are developed markets for CLA, accounting for 85 per cent of the revenues. Meanwhile, Asia is an emerging market, with Japan being the only developed market for CLA, while other countries such as China, Thailand and Korea are potential markets. The increasing incidence of obesity and associated healthcare expenditure have encouraged consumer interest towards weight loss supplements. "The rising incidence of obesity is the key factor driving growth in the global CLA market," notes the analyst of this research service. "In addition, burgeoning health care costs have stimulated consumer interest towards preventive medication." This has augmented the consumption of dietary supplements, which is further propelling growth in the CLA market. Apart from this, heightened media coverage on the ill-effects of obesity has increased consumer awareness and created interest in weight management. Increasing scientific evidence on the efficiency of CLA in weight management and growing demand for fortified foods have encouraged food and beverage manufacturers to incorporate CLA in their products. Moreover, rising scientific evidence of the ability of CLA to alleviate conditions such as diabetes and cardiovascular diseases is likely to open up viable business opportunities for CLA. Resolving Legislative Issues Crucial for Market Growth The uncertain regulatory scenario is a vital factor restricting the use of CLA in a number of applications such as food and beverage, as well as animal feed. In Europe, the regulatory status of CLA is in a grey area as it was introduced prior to the EU's Novel Foods Regulation in 1997. Food ingredients introduced prior to this regulation do not require safety approval by the EC. In addition, according to the French Food Authority, Agence Française de Sécurité Sanitaire des Aliments (AFSSA), the use of CLA in foods and supplements is not justified. "In the United States, CLA holds a self-affirmed GRAS status," remarks the analyst. "While this status of CLA has supported its use in the dietary supplements industry, there are still uncertainties associated with the use of CLA, which have created ambiguity among food and beverage manufacturers regarding the use of this ingredient." Consequently, potential volumes in the food and beverage and animal feed sectors have been restricted. Thus, CLA is largely used as a dietary supplement and its use in the food and beverage, as well as the animal feed industries is significantly hindered by regulatory issues. Nevertheless, these industries are potential application areas, which are likely to witness strong growth rates once legislative issues are resolved. It has been observed that manufacturers are currently focusing on resolving the legislative issues associated with CLA. By working in close coordination with legislative organisations and providing a balanced view on the use of CLA in foods, manufacturers can enhance credibility and encourage its use by food manufacturers. Manufacturers are also likely to benefit from marketing and advertising campaigns aimed at increasing consumer awareness of CLA. Obesity __________________